• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柠檬酸和抗坏血酸作为抗生物膜和抗荚膜剂对多重耐药鲍曼不动杆菌的影响

The Effect of Citric and Ascorbic Acids as Anti-Biofilm and Anti-Capsular Agents on Multidrug-Resistant Acinetobacter baumannii.

作者信息

El-Soudany Ingy, Attia Nancy, Emad Rasha, Rezk Shahinda

机构信息

Microbiology and Immunology Department, Pharos University in Alexandria, Alexandria, Egypt.

Microbiology Department, Medical Research Institute, Alexandria University, Alexandria, Egypt.

出版信息

Med Princ Pract. 2024;33(3):281-290. doi: 10.1159/000537852. Epub 2024 Feb 15.

DOI:10.1159/000537852
PMID:38359804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11175600/
Abstract

OBJECTIVE

Acinetobacter baumannii (A. baumannii) is an opportunistic bacterium with multiple virulence factors, including capsule and biofilm, and is known for its high drug resistance. Anti-virulence natural substances have been suggested as novel alternatives to conventional antibiotics. We aimed to evaluate the effect of citric and ascorbic acids as anti-biofilm and anti-capsular agents against multidrug-resistant (MDR) A. baumannii clinical isolates.

MATERIALS AND METHODS

Twenty-eight A. baumannii MDR isolates were collected from different clinical sources. The minimum inhibitory concentration (MIC) of each agent was estimated. Biofilm formation and capsule were investigated phenotypically in the absence and presence of both agents at ½ and ¼ MICs. The presence of 14 adhesive and nonadhesive virulence genes was investigated.

RESULTS

Phenotypically, all the isolates were biofilm producers and were capsulated. The MIC of citric acid ranged from 1.25 to 2.5 mg/mL, while that of ascorbic acid was 3 mg/mL for all isolates. Both agents showed significant reduction in biofilm and capsular thinning. Ascorbic acid showed a dose-dependent effect in both biofilm reduction and capsule thinning unlike citric acid. Four genes, papG23, sfa1, fyuA, and cvaC, were absent among all isolates, while iutA was present in 100% of isolates. Other genes showed different distributions among the isolates. These virulence genes were not correlated to the anti-biofilm effect of both agents. Ascorbic acid was observed to have a better effect than citric acid. This can provide a clue for a better treatment regimen including ascorbic acid against MDR A. baumannii infections.

摘要

目的

鲍曼不动杆菌是一种具有多种毒力因子(包括荚膜和生物膜)的机会致病菌,以其高耐药性而闻名。抗毒力天然物质已被提议作为传统抗生素的新型替代品。我们旨在评估柠檬酸和抗坏血酸作为抗生物膜和抗荚膜剂对多重耐药(MDR)鲍曼不动杆菌临床分离株的作用。

材料与方法

从不同临床来源收集了28株鲍曼不动杆菌MDR分离株。估计每种药物的最低抑菌浓度(MIC)。在不存在和存在两种药物(分别为½ MIC和¼ MIC)的情况下,对生物膜形成和荚膜进行表型研究。研究了14种黏附性和非黏附性毒力基因的存在情况。

结果

表型上,所有分离株均为生物膜产生菌且具有荚膜。柠檬酸的MIC范围为1.25至2.5 mg/mL,而所有分离株的抗坏血酸MIC均为3 mg/mL。两种药物均显示生物膜显著减少和荚膜变薄。与柠檬酸不同,抗坏血酸在生物膜减少和荚膜变薄方面均显示出剂量依赖性效应。所有分离株中均不存在四种基因,即papG23、sfa1、fyuA和cvaC,而iutA在100%的分离株中存在。其他基因在分离株中的分布不同。这些毒力基因与两种药物的抗生物膜作用无关。观察到抗坏血酸的效果优于柠檬酸。这可为包括抗坏血酸在内的更好治疗方案对抗MDR鲍曼不动杆菌感染提供线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f5/11175600/baef31f898ce/mpp-2024-0033-0003-537852_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f5/11175600/e7bd6ed8f5c7/mpp-2024-0033-0003-537852_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f5/11175600/b3ee78f27692/mpp-2024-0033-0003-537852_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f5/11175600/baef31f898ce/mpp-2024-0033-0003-537852_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f5/11175600/e7bd6ed8f5c7/mpp-2024-0033-0003-537852_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f5/11175600/b3ee78f27692/mpp-2024-0033-0003-537852_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f5/11175600/baef31f898ce/mpp-2024-0033-0003-537852_F03.jpg

相似文献

1
The Effect of Citric and Ascorbic Acids as Anti-Biofilm and Anti-Capsular Agents on Multidrug-Resistant Acinetobacter baumannii.柠檬酸和抗坏血酸作为抗生物膜和抗荚膜剂对多重耐药鲍曼不动杆菌的影响
Med Princ Pract. 2024;33(3):281-290. doi: 10.1159/000537852. Epub 2024 Feb 15.
2
Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii.银纳米颗粒对抗多重耐药鲍曼不动杆菌的抗生物膜和抗病毒活力潜力。
Sci Rep. 2021 May 24;11(1):10751. doi: 10.1038/s41598-021-90208-4.
3
Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients.从重症监护病房患者中分离出的多重耐药生物膜形成鲍曼不动杆菌的毒力特征。
BMC Infect Dis. 2019 Jul 17;19(1):629. doi: 10.1186/s12879-019-4272-0.
4
Virulence properties of multidrug resistant ocular isolates of Acinetobacter baumannii.鲍曼不动杆菌多重耐药眼部分离株的毒力特性
Curr Eye Res. 2014 Jul;39(7):695-704. doi: 10.3109/02713683.2013.873055. Epub 2014 Feb 6.
5
Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.重症患者中替加环素耐药鲍曼不动杆菌的基因组和表型演变。
Microbiol Spectr. 2022 Feb 23;10(1):e0159321. doi: 10.1128/spectrum.01593-21. Epub 2022 Jan 19.
6
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.分析 ICU 患者下呼吸道感染的鲍曼不动杆菌分离株的表型和分子特征。
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
7
Correlation of biofilm formation and antibiotic resistance among clinical and soil isolates of Acinetobacter baumannii in Iraq.伊拉克临床和土壤分离的鲍曼不动杆菌的生物膜形成与抗生素耐药相关性研究。
Acta Microbiol Immunol Hung. 2020 Oct 21;67(3):161-170. doi: 10.1556/030.66.2019.026.
8
Sub-minimum inhibitory concentrations (sub-MICs) of colistin on biofilm formation potency, adherence, and invasion to epithelial host cells: an experimental study in an Iranian children's referral hospital.多粘菌素亚最小抑菌浓度(sub-MICs)对生物膜形成能力、黏附及侵袭上皮宿主细胞的影响:伊朗一家儿童医院的实验研究。
Microbiol Spectr. 2024 Feb 6;12(2):e0252323. doi: 10.1128/spectrum.02523-23. Epub 2024 Jan 17.
9
[Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].[多重耐药鲍曼不动杆菌分离株毒力因子的研究]
Mikrobiyol Bul. 2014 Jan;48(1):70-81.
10
Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.LL-37 片段 GF-17D3 和蜈蚣 A2 肽对耐甲氧西林金黄色葡萄球菌、铜绿假单胞菌和鲍曼不动杆菌的体外和体内模型研究的抗菌性能和功效。
Probiotics Antimicrob Proteins. 2024 Jun;16(3):796-814. doi: 10.1007/s12602-023-10070-w. Epub 2023 May 6.

本文引用的文献

1
Portrait of a killer: Uncovering resistance mechanisms and global spread of Acinetobacter baumannii.杀手的画像:揭示鲍曼不动杆菌的耐药机制和全球传播。
PLoS Pathog. 2023 Aug 10;19(8):e1011520. doi: 10.1371/journal.ppat.1011520. eCollection 2023 Aug.
2
Moving toward Extensively Drug-Resistant: Four-Year Antimicrobial Resistance Trends of from the Largest Department of Internal Medicine in Slovakia.迈向广泛耐药:斯洛伐克最大内科部门的四年抗菌药物耐药性趋势
Antibiotics (Basel). 2023 Jul 18;12(7):1200. doi: 10.3390/antibiotics12071200.
3
Diminishing the Pathogenesis of the Food-Borne Pathogen by Low Doses of Sodium Citrate.
低剂量柠檬酸钠减轻食源性病原体的发病机制
Biology (Basel). 2023 Mar 26;12(4):504. doi: 10.3390/biology12040504.
4
Attenuating the virulence of the resistant superbug Staphylococcus aureus bacteria isolated from neonatal sepsis by ascorbic acid, dexamethasone, and sodium bicarbonate.用抗坏血酸、地塞米松和碳酸氢钠来减弱从新生儿败血症中分离出来的耐药超级细菌金黄色葡萄球菌的毒力。
BMC Microbiol. 2022 Nov 9;22(1):268. doi: 10.1186/s12866-022-02684-x.
5
Computer-Based Identification of Potential Druggable Targets in Multidrug-Resistant : A Combined In Silico, In Vitro and In Vivo Study.基于计算机的多重耐药潜在可成药靶点鉴定:一项计算机模拟、体外和体内联合研究
Microorganisms. 2022 Oct 5;10(10):1973. doi: 10.3390/microorganisms10101973.
6
Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline.鲍曼不动杆菌:发病机制、毒力因子、新型治疗选择以及对抗微生物药物的耐药机制,重点关注替加环素。
J Clin Pharm Ther. 2022 Nov;47(11):1875-1884. doi: 10.1111/jcpt.13787. Epub 2022 Oct 6.
7
An Overview of Biofilm Formation-Combating Strategies and Mechanisms of Action of Antibiofilm Agents.生物膜形成的对抗策略及抗生物膜剂作用机制概述
Life (Basel). 2022 Jul 23;12(8):1110. doi: 10.3390/life12081110.
8
Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Clinical Isolates.维生素C对临床分离株的抗菌及抗生物膜作用评估
Front Microbiol. 2022 May 20;13:847449. doi: 10.3389/fmicb.2022.847449. eCollection 2022.
9
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.抗生素耐药菌:现状与治疗选择,以加速新抗菌药物的研发。
Expert Rev Anti Infect Ther. 2022 Aug;20(8):1095-1108. doi: 10.1080/14787210.2022.2078308. Epub 2022 May 31.
10
Bactericidal, anti-biofilm, and anti-virulence activity of vitamin C against carbapenem-resistant hypervirulent .维生素C对耐碳青霉烯类高毒力菌的杀菌、抗生物膜及抗毒力活性
iScience. 2022 Feb 8;25(3):103894. doi: 10.1016/j.isci.2022.103894. eCollection 2022 Mar 18.